Article Details
Retrieved on: 2021-04-01 15:49:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
When Matinas BioPharma Holdings last reported its balance sheet in December 2020, it had zero debt and cash worth US$59m. In the last year, its cash ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here